Other
GH Deficiency
0
Pipeline Programs↗
1
Active Trials↗
0
Companies Involved↗
GH Deficiency is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
3
clinical trials
Completed2 · 67%
Active, not recruiting1 · 33%
Clinical Trials
Trial Activity
Adipose Tissue and Circulating Markers of Inflammation in GH Deficiency and Changes With GH Therapy
Completed·—·N/A·NCT03225755·7 enrolled
Adipose Tissue and Serum Inflammation in GH Deficiency
Completed·—·N/A·NCT03500913·19 enrolled
Vesiculogenesis in Children With GH Deficiency (VESCIGHTP)
Active, not recruiting·—·N/A·NCT05759624·10 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)